New Screening and Diagnostic Cut-off Points of PA Patients — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

New Screening and Diagnostic Cut-off Points of PA Patients — Stella

Home/Primary Aldosteronism/

View on ClinicalTrials.gov

Recruiting

Back to Primary Aldosteronism trials

Trial locations(1 site)

China

Kai-juan Wang, Beijing

Key details

Sponsor

China National Center for Cardiovascular Diseases

Collaborators

Beijing Anzhen Hospital, First Affiliated Hospital of Chongqing Medical University

Enrollment target

~770 participants

Started

January 2024

Primary completion

October 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 75 Years

Last updated August 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.